Pattern of Recurrence in Radically Treated Triple Negative Breast Cancer Patients
- 1 Department of Radiation Oncology, Government Medical College, Trivandrum, India
- 2 Department of Radiation Oncology, Government Medical College, Trivandrum, India
- 3 Achutha Menon Centre, SCTIMST, Trivandrum, India
Abstract
Background: In India approximately 20% of the patients with breast cancer are triple receptor negative. Owing to the aggressive nature and shorter disease-free survival judicious follow up and identification of failure pattern will benefit the patient. Similar studies have been conducted among non-Hispanic population and in China. This study aims to identify failure pattern in radically treated breast cancer patients who are triple receptor negative among Indian population. Methods : This prospective observational study was conducted in the Department of Radiation Oncology, a tertiary cancer centre in Kerala, India. The objective was to record the pattern of recurrence among triple negative breast cancer patients who completed their planned radical treatment. 171 patients with triple negative breast cancer were included in the study. Patients who completed the planned radical treatment were kept under regular follow up. Details of clinical examination and investigations during the follow up were recorded periodically. Results : Out of 171 patients 30 patients had a recurrence of disease. Median age of the population was 53 years. Among the 30 patients who had a recurrence, 16 patients (53%) had systemic relapse and 14 patients (47%) had locoregional relapse. Lung was found to be the most common site of distant metastasis (37%). Ipsilateral chest wall was found to be the most common site of locoregional relapse (50%). 6 months disease free survival was found to be 91.8% and 1-year disease free survival was found to be 70.2%. Conclusion : Among radically treated triple negative breast cancers relapses, systemic recurrence was more than locoregional recurrences.
- Cleator, S., Heller, W. and Coombes, R.C. (2007) Triple-Negative Breast Cancer: Therapeutic Options. The Lancet Oncology, 8, 235-244. https://doi.org/10.1016/S1470-2045(07)70074-8
- Rakha, E.A., El-Sayed, M.E., Green, A.R., Lee, A.H.S., Robertson, J.F. and Ellis, I.O. (2007) Prognostic Markers in Triple-Negative Breast Cancer. Cancer, 109, 25-32. https://doi.org/10.1002/cncr.22381
- Wang, S.-L., Li, Y.-X., Song, Y.-W., Wang, W.-H., Jin, J., Liu, Y.-P., et al. (2011) Triple-Negative or HER2-Positive Status Predicts Higher Rates of Locoregional Recurrence in Node-Positive Breast Cancer Patients after Mastectomy. International Journal of Radiation Oncology, 80, 1095-1101. https://doi.org/10.1016/j.ijrobp.2010.03.038
- Abdulkarim, B.S., Cuartero, J., Hanson, J., Deschênes, J., Lesniak, D. and Sabri, S. (2011) Increased Risk of Locoregional Recurrence for Women with T1-2N0 Triple-Negative Breast Cancer Treated with Modified Radical Mastectomy without Adjuvant Radiation Therapy Compared with Breast-Conserving Therapy. Journal of Clinical Oncology, 29, 2852-2858. https://doi.org/10.1200/JCO.2010.33.4714
- Chen, V.E., Gillespie, E.F., Zakeri, K., Murphy, J.D., Yashar, C.M., Lu, S., et al. (2017) Pathologic Response after Neoadjuvant Chemotherapy Predicts Locoregional Control in Patients with Triple Negative Breast Cancer. Advances in Radiation Oncology, 2, 105-109. https://doi.org/10.1016/j.adro.2017.01.012
- Liedtke, C., Mazouni, C., Hess, K.R., André, F., Tordai, A., Mejia, J.A., et al. (2008) Response to Neoadjuvant Therapy and Long-Term Survival in Patients with Triple-Negative Breast Cancer. Journal of Clinical Oncology, 26, 1275-1281. https://doi.org/10.1200/JCO.2007.14.4147
- Lebert, J.M., Lester, R., Powell, E., Seal, M. and McCarthy, J. (2018) Advances in the Systemic Treatment of Triple-Negative Breast Cancer. Current Oncology, 25, 142-150. https://doi.org/10.3747/co.25.3954
- Zaky, S.S., Lund, M., May, K.A., Godette, K.D., Beitler, J.J., Holmes, L.R., et al. (2011) The Negative Effect of Triple-Negative Breast Cancer on Outcome after Breast-Conserving Therapy. Annals of Surgical Oncology, 18, 2858-2865. https://doi.org/10.1245/s10434-011-1669-4
- Perou, C.M. (2011) Molecular Stratification of Triple-Negative Breast Cancers. The Oncologist, 16, 61-70. https://doi.org/10.1634/theoncologist.2011-S1-61
- Prasad, S., Efird, J.T., James, S.E., Walker, P.R., Zagar, T.M. and Biswas, T. (2016) Failure Patterns and Survival Outcomes in Triple Negative Breast Cancer (TNBC): A 15 Year Comparison of 448 Non-Hispanic Black and White Women. SpringerPlus, 5, Article No. 756. https://doi.org/10.1186/s40064-016-2444-6